Press Releases

<< Back
Feb 19, 2013

Herbalife Ltd. Announces Record Fourth Quarter 2012 and Record Full Year Results, and Raises 2013 Earnings Guidance

 

  • Fourth quarter worldwide volume growth of 18 percent with double-digit increases in each of its six regions compared to the prior year period.
  • Fourth quarter EPS of $1.05 increased 22 percent compared to the prior year.
  • Raising FY'13 EPS guidance to a range of $4.45 to $4.65.
  • Annual sales leader retention of approximately 51.8 percent.
  • Repurchased 4.0 million shares of stock since December 31, 2012.
  • Board of directors approved a $0.30 per share quarterly dividend.

LOS ANGELES--(BUSINESS WIRE)-- Herbalife Ltd. (NYSE: HLF) today reported fourth quarter net sales of $1.1 billion, reflecting an increase of 20 percent compared to the same time period in 2011 on volume point growth of 18 percent. Net income for the quarter of $117.8 million, or $1.05 per diluted share, compares to 2011 fourth quarter net income of $105.4 million and EPS of $0.86, respectively.

For the twelve months ended December 31, 2012, the company reported record net sales of $4.1 billion, an 18 percent increase on 20 percent growth in volume compared to 2011. For the same period, the company reported net income of $477.2 million, or $4.05 per diluted share, reflecting an increase of 16 percent and 23 percent, respectively, compared to the 2011 results of $412.6 million and $3.30 per diluted share.

"Herbalife continues to deliver record results in sales and profitability as our independent distributors go deeper into existing markets, developing more and more customers using our nutrition products every day," said Michael O. Johnson, Herbalife's chairman and CEO. "Obesity and poor nutrition are global public health problems. Our distributors are proud to be part of the solution."

For the year ended December 31, 2012 the company generated cash flow from operations of $567.8 million, an increase of 11 percent compared to 2011; paid dividends of $135.1 million; invested $122.8 million in capital expenditures; and repurchased $527.8 million in common shares outstanding under our share repurchase program.

Fourth Quarter and Fiscal 2012 Regional Key Metrics1,2

Regional Volume Point and Average Active Sales Leader Metrics

  Volume Points (Mil)   Average Active Sales Leaders
Region 4Q'12   Yr/Yr % Chg   4Q'12   Yr/Yr % Chg
North America 267.0   15%   68,029   14%
Asia Pacific 304.6   18%   69,553   26%
EMEA 156.6   14%   47,226   14%
Mexico 208.9   13%   61,836   19%
South & Central America 222.5   34%   50,874   28%
China 50.5   17%   12,560   25%
Worldwide Total 1,210.1   18%   300,521   20%
  Volume Points (Mil)   Average Active Sales Leaders
Region FY'12   Yr/Yr % Chg   FY'12   Yr/Yr % Chg
North America 1,157.8   17%   66,054   16%
Asia Pacific 1,197.8   25%   63,255   31%
EMEA 602.5   11%   44,098   14%
Mexico 815.4   16%   57,651   21%
South & Central America 740.4   30%   44,980   29%
China 206.5   34%   11,683   33%
Worldwide Total 4,720.4   20%   277,803   22%

2012 Annual Sales Leader Requalification

By the end of January of each year, sales leaders are required to re-qualify to retain their sales leader status. A record number of sales leaders were retained in 2012. The overall pool of sales leaders needing to re-qualify increased by approximately 21% compared to the prior year and we retained 20% more of them than in the prior year. While size of the group needing to re-qualify increased for the year, our overall retention rate remained fairly constant at 51.8%.

________________________________________
1Supplemental tables that include additional business metrics can be found at http://www.ir.herbalife.com.

2Worldwide Average Active Sales Leaders may not equal the sum of the Average Active Sales Leaders in each region due to the calculation being an average of Sales Leaders active in a period, not a summation, and the fact that some sales leaders are active in more than one region but are counted only once in the worldwide amount.

Updated 2013 Guidance

Guidance for fully diluted 2013 EPS is based on the average daily exchange rates of January 2013, which in aggregate are not materially different from the foreign currency exchange rates assumed in our prior guidance. Our 2013 guidance continues to assume a Venezuelan exchange rate of 10 to 1. The guidance does not include the one-time impact associated with the revaluation of our bolivar denominated monetary assets and monetary liabilities, which includes our bolivar denominated cash, due to the recent devaluation of the Venezuelan bolivar, or any potential one-time impact from a future devaluation or the repatriation of existing cash balances. Guidance for the year also excludes one-time costs of $10 million to $20 million, mostly legal and advisory services, relating to the Company's response to information put into the marketplace by a short seller which information the Company believes to be inaccurate and misleading.

Based on current business trends the company's first quarter fiscal 2013 and fiscal 2013 guidance is provided below.

  Three Months Ending   Twelve Months Ending
  March 31, 2013  

December 31, 2013

  Low   High   Low   High
Volume Point Growth vs 2012 11.5%   13.5%   8.5%   10.5%
Net Sales Growth vs 2012 15.0%   17.0%   12.0%   14.0%
Diluted EPS $1.03   $1.07   $4.45   $4.65
Cap Ex ($ millions) $20.0   $30.0   $165.0   $185.0
Effective Tax Rate 28.5%   30.5%   27.5%   29.5%

Announces Quarterly Dividend

The company reported today that its board of directors has approved a dividend of $0.30 per share to shareholders of record March 5, 2013, payable on March 19, 2013.

Share Repurchase Program Update

Subsequent to December 31, 2012, the company has repurchased 4.0 million shares at an average cost of $40.61. There is currently $787.6 million remaining on the existing $1 billion share repurchase authorization.

Fourth Quarter and Fiscal 2012 Earnings Conference Call

Herbalife senior management will host an investor conference call to discuss its recent financial results and provide an update on current business trends on Wednesday, February 20, 2013 at 8 a.m. PST (11 a.m. EST).

The dial-in number for this conference call for domestic callers is (877) 317-1296 and (706) 634-5671 for international callers (conference ID 90082326). Live audio of the conference call will be simultaneously webcast in the investor relations section of the company's website at http://ir.herbalife.com.

An audio replay will be available following the completion of the conference call in MP3 format or by dialing (855) 859-2056 for domestic callers or (404) 537-3406 for international callers (conference ID 90082326). The webcast of the teleconference will be archived and available on Herbalife's website.

About Herbalife Ltd.

Herbalife Ltd. (NYSE:HLF) is a global nutrition company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle.Herbalife products are sold in over 80 countries through and to a network of independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to help bring good nutrition to children. Herbalife's website contains a significant amount of information about Herbalife, including financial and other information for investors at http://ir.Herbalife.com. The company encourages investors to visit its website from time to time, as information is updated and new information is posted.

FORWARD-LOOKING STATEMENTS

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements include, among others, the following:

• any collateral impact resulting from the ongoing worldwide financial environment including the availability of liquidity to us, our customers and our suppliers or the willingness of our customers to purchase products in a difficult economic environment;

• our relationship with, and our ability to influence the actions of, our distributors;

• improper action by our employees or distributors in violation of applicable law;

• adverse publicity associated with our products or network marketing organization, including our ability to comfort the marketplace and regulators regarding our compliance with applicable laws;

• changing consumer preferences and demands;

• our reliance upon, or the loss or departure of any member of, our senior management team which could negatively impact our distributor relations and operating results;

• the competitive nature of our business;

• regulatory matters governing our products, including potential governmental or regulatory actions concerning the safety or efficacy of our products and network marketing program, including the direct selling market in which we operate;

• legal challenges to our network marketing program;

• risks associated with operating internationally and the effect of economic factors, including foreign exchange, inflation, disruptions or conflicts with our third party importers, pricing and currency devaluation risks, especially in countries such as Venezuela;

• uncertainties relating to the application of transfer pricing, duties, value added taxes, and other tax regulations, and changes thereto;

• uncertainties relating to interpretation and enforcement of legislation in China governing direct selling;

• our inability to obtain the necessary licenses to expand our direct selling business in China;

• adverse changes in the Chinese economy, Chinese legal system or Chinese governmental policies;

• our dependence on increased penetration of existing markets;

• contractual limitations on our ability to expand our business;

• our reliance on our information technology infrastructure and outside manufacturers;

• the sufficiency of trademarks and other intellectual property rights;

• product concentration;

• changes in tax laws, treaties or regulations, or their interpretation;

• taxation relating to our distributors;

• product liability claims;

• whether we will purchase any of our shares in the open markets or otherwise; and

• share price volatility related to, among other things, speculative trading and certain traders shorting our common shares.

We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

RESULTS OF OPERATIONS:

Herbalife Ltd.
Condensed Consolidated Statements of Income
(In thousands, except per share amounts)
(Unaudited)
               
  Three Months Ended   Twelve Months Ended
    12/31/2012     12/31/2011       12/31/2012     12/31/2011
               
North America $ 197,052   $ 165,737     $ 841,243   $ 698,631
Mexico   132,070     106,192       496,101     436,930
South and Central America   203,252     155,373       688,799     554,439
EMEA   164,684     151,556       627,801     615,180
Asia Pacific   295,166     247,015       1,139,867     938,590
China   67,096     58,696       278,519     210,767
Worldwide net sales   1,059,320     884,569       4,072,330     3,454,537
Cost of Sales   211,105     170,960       812,583     680,084
Gross Profit   848,215     713,609       3,259,747     2,774,453
Royalty Overrides   355,658     293,109       1,338,633     1,137,560
SGA   332,764     286,151       1,259,667     1,074,623
Operating Income   159,793     134,349       661,447     562,270
Interest Expense - net   2,453     (1,357 )     10,541     2,491
Income before income taxes   157,340     135,706       650,906     559,779
Income Taxes   39,459     30,349       173,716     147,201
Net Income   117,881     105,357       477,190     412,578
               
Basic Shares   107,444     115,989       112,359     117,540
Diluted Shares   112,230     122,640       117,856     124,846
               
Basic EPS $ 1.10   $ 0.91     $ 4.25   $ 3.51
Diluted EPS $ 1.05   $ 0.86     $ 4.05   $ 3.30
               
Dividends declared per share $ 0.30   $ 0.20     $ 1.20   $ 0.73
               

 

Herbalife Ltd.
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
  Dec 31,   Dec 31,
    2012       2011  
       
ASSETS      
Current Assets:      
Cash & cash equivalents $ 333,534     $ 258,775  
Receivables, net   116,139       89,660  
Inventories   339,411       247,696  
Prepaid expenses and other current assets   125,425       117,073  
Deferred income taxes   49,339       55,615  
Total Current Assets   963,848       768,819  
       
Property, plant and equipment, net   242,886       193,703  
Deferred compensation plan assets   24,267       20,511  
Other assets   48,805       41,125  
Deferred financing cost, net   7,462       4,797  
Marketing related intangibles and other intangible assets, net   311,186       311,764  
Goodwill   105,490       105,490  
Total Assets $ 1,703,944     $ 1,446,209  
       
       
LIABILITIES AND SHAREHOLDERS' EQUITY      
Current Liabilities:      
Accounts payable $ 75,209     $ 57,095  
Royalty overrides   243,351       197,756  
Accrued compensation   95,220       76,435  
Accrued expenses   181,523       152,744  
Current portion of long term debt   56,302       1,542  
Advance sales deposits   49,432       31,702  
Income taxes payable   15,854       31,415  
Total Current Liabilities   716,891       548,689  
       
Non-current liabilities      
Long-term debt, net of current portion   431,305       202,079  
Deferred compensation plan liability   29,454       23,702  
Deferred income taxes   62,982       72,348  
Other non-current liabilities   42,557       39,203  
Total Liabilities   1,283,189       886,021  
       
Commitments and Contingencies      
       
Shareholders' equity:      
Common shares   107       116  
Paid-in capital in excess of par value   303,975       291,950  
Accumulated other comprehensive loss   (31,695 )     (37,809 )
Retained earnings   148,368       305,931  
Total Shareholders' Equity   420,755       560,188  
       
Total Liabilities and Shareholders' Equity $ 1,703,944     $ 1,446,209  
               

 

Herbalife Ltd.
Condensed Consolidated Statements of Cash Flows
(In thousands)

(Unaudited)

 

       
    Twelve Months Ended
    12/31/2012   12/31/2011
CASH FLOWS FROM OPERATING ACTIVITIES        
Net income   $ 477,190     $ 412,578  
Adjustments to reconcile net income to net cash provided by        
operating activities:        
Depreciation and amortization     74,384       71,853  
Excess tax benefits from share-based payment arrangements     (29,684 )     (27,450 )
Share based compensation expenses     27,906       24,133  
Amortization of discount and deferred financing costs     1,797       1,007  
Deferred income taxes     (9,050 )     (12,984 )
Unrealized foreign exchange transaction loss (gain)     2,121       9,403  
Write-off of deferred financing costs     -       914  
Other     532       2,206  
Changes in operating assets and liabilities:        
Receivables     (28,186 )     (9,687 )
Inventories     (82,177 )     (84,880 )
Prepaid expenses and other current assets     249       3,229  
Other assets     (5,288 )     (13,864 )
Accounts payable     17,034       15,427  
Royalty overrides     41,868       44,041  
Accrued expenses and accrued compensation     39,440       28,749  
Advance sales deposits     17,790       (1,538 )
Income taxes     16,106       42,659  
Deferred compensation plan liability     5,752       3,535  
NET CASH PROVIDED BY OPERATING ACTIVITIES     567,784       509,331  
CASH FLOWS FROM INVESTING ACTIVITIES        
Purchases of property, plant and equipment     (121,524 )     (90,408 )
Proceeds from sale of property, plant and equipment     280       297  
Deferred compensation plan assets     (3,756 )     (1,975 )
NET CASH USED IN INVESTING ACTIVITIES     (125,000 )     (92,086 )
CASH FLOWS FROM FINANCING ACTIVITIES        
Dividends paid     (135,091 )     (85,489 )
Borrowings from long-term debt     1,430,560       914,200  
Principal payments on long-term debt     (1,146,580 )     (888,865 )
Deferred financing costs     (4,460 )     (5,718 )
Share repurchases     (556,727 )     (321,639 )
Excess tax benefits from share-based payment arrangements     29,684       27,450  
Proceeds from exercise of stock options and sale of stock under        
employee stock purchase plan     11,373       22,262  
NET CASH USED IN FINANCING ACTIVITIES     (371,241 )     (337,799 )
EFFECT OF EXCHANGE RATE CHANGES ON CASH     3,216       (11,221 )
NET CHANGE IN CASH AND CASH EQUIVALENTS     74,759       68,225  
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR     258,775       190,550  
CASH AND CASH EQUIVALENTS, END OF YEAR     333,534       258,775  
CASH PAID DURING THE YEAR        
Interest paid   $ 14,268     $ 8,800  
Income taxes paid   $ 169,725     $ 118,906  

 

SUPPLEMENTAL INFORMATION

SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(unaudited), (Dollars in Thousand, Except Per Share Data)

In addition to its reported results, the Company has included in the tables below adjusted results that the Securities and Exchange Commission defines as "non-GAAP financial measures." Management believes that such non-GAAP financial measures, when read in conjunction with the Company's reported results, can provide useful supplemental information for investor in analyzing period to period comparisons of the Company's results.

The following is a reconciliation of net income and diluted earnings per share, presented and reported in accordance with U.S. generally accepted accounting principles, to net income adjusted for certain items:

    Three Months Ended   Twelve Months Ended
    12/31/2012   12/31/2011   12/31/2012   12/31/2011
                 
Net income, as reported   $ 117,881   $ 105,357   $ 477,190   $ 412,578
Write-off of unamortized deferred financing cost                
from debt refinancing (net of $214 tax benefit)   -   -   -   700
Net income, as adjusted   $ 117,881   $ 105,357   $ 477,190   $ 413,278

The following is a reconciliation of diluted earnings per share, presented and reported in accordance with U.S. generally accepted accounting principles, to diluted earnings per share adjusted for certain items:

    Three Months Ended   Twelve Months Ended
    12/31/2012   12/31/2011   12/31/2012   12/31/2011
                 
Diluted earnings per share, as reported   $ 1.05   $ 0.86   $ 4.05   $ 3.30
Write-off of unamortized deferred financing cost                
from debt refinancing   -   -   -   0.01
Diluted earnings per share, as adjusted   $ 1.05   $ 0.86   $ 4.05   $ 3.31

 

The following is a reconciliation of total long-term debt to net debt:

      12/31/2012     12/31/2011  
         
Total long-term debt (current and long-term portion)   $ 487,607   $ 203,621  
Less: Cash and cash equivalents     333,534     258,775  
Net debt   $ 154,073   $ (55,154 )

 

Media Contact:
Barbara Henderson
SVP, Worldwide Corp. Comm.
213.745.0517
or
Investor Contact:
Amy Greene
VP, Investor Relations
213.745.0474

Source: Herbalife Ltd.

 

 

News Provided by Acquire Media